AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

Partners Regeneron and Sanofi say itepekimab only achieved a significantly statistic result in one of two studies.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...